Poland· PL-100222335
Amisan
A amisulpride product containing amisulpridum, registered in Poland by PRO.MED.CS Praha a.s.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Amisulpride is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AL05 (amisulpride), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Amisulpride · ATC N05AL05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of amisulpride costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.37 in France to $2.49 in Switzerland — a ×1.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Amisulpride · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.49
- IT Italy$1.87
- FR France$1.37
The record
At a glance
URPL (Poland)- Active substance
- Amisulpridum
- Manufacturer
- PRO.MED.CS Praha a.s.
- Country
- Poland (PL)
- ATC code
- N05AL05
- ATC class
- Amisulpride
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0590999076288060 szt.PLN 31.06
- gtin05909990762873
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
228 interactions on record for amisulpride.
Graded by severity as the source publishes them — 126 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amisulpride · interactions on record
228 records
- 126 severe
- 49 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
51 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amisulpride in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKTIPROLMedochemie Ltd., Limassol
- United KingdomAmisulpride 50mg tabletsSigma Pharmaceuticals Plc
- NetherlandsAktiprol 50 mg tablettenProlepha Research B.V.
- NorwayAmisulprid purenPuren
- IrelandAmisulpride 50 mg TabletsViatris Limited
- IcelandSolianSanofi-aventis Norge AS
- FranceAMISULPRIDE ARROW 100 mg, comprimé sécableARROW GENERIQUES
- BelgiumAlpridemylan 100 mgViatris GX
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Amisu, Solian
- Belgium · Amisulpride Eg, Solian
- Bulgaria · Alonet, Медосулпид
- Cyprus · Aktiprol, Solian
- Czechia · Aktiprol, Amilia
- Germany · Amisulprid Aaa, Amisulprid Mylan
- Denmark · Aktiprol, Amisulprid Dlf
- Estonia · Amisan, Solian
- Spain · Amisulprida Aurovitas, Amisulprida Normon
- France · Amisulpride Arrow Lab, Amisulpride Biogaran
- United Kingdom (Northern Ireland) · Amisulpride, Amisulpride Accord-Uk
- Greece · Isofredil, Nodasic
- Croatia · Aktiprol, Solian
- Hungary · Amisulprid Ratiopharm, Amitrex
- Ireland · Amisulpride Mylan, Solian
- Iceland · Solian
- Italy · Amisulpride Aurobindo, Amisulpride Doc
- Lithuania · Aktiprol, Amisan
- Luxembourg · Amisulpride Eg, Solian
- Latvia · Aktiprol, Solian
- Malta · Aktiprol, Amisulpride Syri Pharma
- Netherlands · Aktiprol
- Norway · Solian
- Portugal · Amissulprida Aurobindo, Amissulprida Aurovitas
- Romania · Masultab, Midora
- Slovenia · Solian
- Slovakia · Aktiprol, Amisulprid Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7e0a51aa-907a-45c4-9dd5-5b3f4adaa2e5 GET /v1/drugs/7e0a51aa-907a-45c4-9dd5-5b3f4adaa2e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909990762873 ¦ Rp ¦ 56178\n12 tabl.\n05909990762880 ¦ Rp ¦ 56179\n60 tabl.",
"substance": "Amisulpridum 50 mg",
"common_name": "Amisulpridum",
"pl_product_id": "100222335",
"pozwolenie_nr": "16388",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about amisulpride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.